BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 33773497)

  • 1. Validation of the 'Inflammatory Bowel Disease-Distribution, Chronicity, Activity [IBD-DCA] Score' for Ulcerative Colitis and Crohn´s Disease.
    Lang-Schwarz C; Angeloni M; Agaimy A; Atreya R; Becker C; Dregelies T; Danese S; Fléjou JF; Gaßler N; Grabsch HI; Hartmann A; Kamarádová K; Kühl AA; Lauwers GY; Lugli A; Nagtegaal I; Neurath MF; Oberhuber G; Peyrin-Biroulet L; Rath T; Riddell R; Rubio CA; Sheahan K; Siegmund B; Tilg H; Villanacci V; Westerhoff M; Ferrazzi F; Vieth M
    J Crohns Colitis; 2021 Oct; 15(10):1621-1630. PubMed ID: 33773497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological Indices and Risk of Recurrence in Crohn's Disease: A Retrospective Study of a Cohort of Patients in Endoscopic Remission.
    Marion L; Amélie B; Zoubir D; Guillaume C; Elise MS; Hedia B; Margaux LS; Aude M; Camille BR
    Inflamm Bowel Dis; 2022 Sep; 28(9):1395-1404. PubMed ID: 35429159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simple mucosal biopsy criteria differentiating among Crohn disease, ulcerative colitis, and other forms of colitis: measurement of validity.
    Tanaka M; Saito H; Fukuda S; Sasaki Y; Munakata A; Kudo H
    Scand J Gastroenterol; 2000 Mar; 35(3):281-6. PubMed ID: 10766322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observer variation of diagnoses based on simple biopsy criteria differentiating among Crohn's disease, ulcerative colitis, and other forms of colitis.
    Tanaka M; Masuda T; Yao T; Saito H; Kusumi T; Nagura H; Kudo H
    J Gastroenterol Hepatol; 2001 Dec; 16(12):1368-72. PubMed ID: 11851834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Toronto IBD Global Endoscopic Reporting [TIGER] Score: A Single, Easy to Use Endoscopic Score for Both Crohn's Disease and Ulcerative Colitis Patients.
    Zittan E; Steinhart AH; Aran H; Milgrom R; Gralnek IM; Zelber-Sagi S; Silverberg MS
    J Crohns Colitis; 2022 May; 16(4):544-553. PubMed ID: 34272937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of the Montreal classification for inflammatory bowel diseases.
    Spekhorst LM; Visschedijk MC; Alberts R; Festen EA; van der Wouden EJ; Dijkstra G; Weersma RK;
    World J Gastroenterol; 2014 Nov; 20(41):15374-81. PubMed ID: 25386087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Simplified Geboes Score for Ulcerative Colitis.
    Jauregui-Amezaga A; Geerits A; Das Y; Lemmens B; Sagaert X; Bessissow T; Lobatón T; Ferrante M; Van Assche G; Bisschops R; Geboes K; De Hertogh G; Vermeire S
    J Crohns Colitis; 2017 Mar; 11(3):305-313. PubMed ID: 27571771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep Learning Models Capture Histological Disease Activity in Crohn's Disease and Ulcerative Colitis with High Fidelity.
    Rymarczyk D; Schultz W; Borowa A; Friedman JR; Danel T; Branigan P; Chałupczak M; Bracha A; Krawiec T; Warchoł M; Li K; De Hertogh G; Zieliński B; Ghanem LR; Stojmirovic A
    J Crohns Colitis; 2024 Apr; 18(4):604-614. PubMed ID: 37814351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
    World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of a Patient-reported Score to Screen for Mucosal Inflammation in Inflammatory Bowel Disease.
    de Jong MJ; Roosen D; Degens JHRJ; van den Heuvel TRA; Romberg-Camps M; Hameeteman W; Bodelier AGL; Romanko I; Lukas M; Winkens B; Markus T; Masclee AAM; van Tubergen A; Jonkers DMAE; Pierik MJ
    J Crohns Colitis; 2019 Apr; 13(5):555-563. PubMed ID: 30476099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis.
    Tanaka M; Riddell RH; Saito H; Soma Y; Hidaka H; Kudo H
    Scand J Gastroenterol; 1999 Jan; 34(1):55-67. PubMed ID: 10048734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis.
    Mohammed Vashist N; Samaan M; Mosli MH; Parker CE; MacDonald JK; Nelson SA; Zou GY; Feagan BG; Khanna R; Jairath V
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011450. PubMed ID: 29338066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
    Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L
    Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trial.
    Jairath V; Peyrin-Biroulet L; Zou G; Mosli M; Vande Casteele N; Pai RK; Valasek MA; Marchal-Bressenot A; Stitt LW; Shackelton LM; Khanna R; D'Haens GR; Sandborn WJ; Olson A; Feagan BG; Pai RK
    Gut; 2019 Jul; 68(7):1162-1168. PubMed ID: 30076171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
    Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
    Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologic scoring indices for evaluation of disease activity in ulcerative colitis.
    Mosli MH; Parker CE; Nelson SA; Baker KA; MacDonald JK; Zou GY; Feagan BG; Khanna R; Levesque BG; Jairath V
    Cochrane Database Syst Rev; 2017 May; 5(5):CD011256. PubMed ID: 28542712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical Use.
    Subramanian S; Asher R; Weston W; Rimmer M; McConville A; Malin A; Jackson R; Collins P; Probert C; Dibb M; Rhodes JM
    Inflamm Bowel Dis; 2016 Aug; 22(8):1902-7. PubMed ID: 27243590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is ischemia modified albumin a disease activity marker for inflammatory bowel diseases?
    Kaplan M; Yuksel M; Ates I; Kilic ZM; Kilic H; Kuzu UB; Kayacetin E
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1120-5. PubMed ID: 26642816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
    Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
    Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproducibility of histological assessments of disease activity in UC.
    Mosli MH; Feagan BG; Zou G; Sandborn WJ; D'Haens G; Khanna R; Behling C; Kaplan K; Driman DK; Shackelton LM; Baker KA; MacDonald JK; Vandervoort MK; Samaan MA; Geboes K; Valasek MA; Pai R; Langner C; Riddell R; Harpaz N; Sewitch M; Peterson M; Stitt LW; Levesque BG
    Gut; 2015 Nov; 64(11):1765-73. PubMed ID: 25360036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.